According to the latest report by IMARC Group, titled “Neurosurgery Devices Market Report by Product Type (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid (CSF) Management Devices, and Others), Application (Spinal Cord Stimulation, Deep Brain Stimulation, Neuroendoscopy), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032,” the global neurosurgery devices market reached a value of US$ 11.6 Billion in 2023. Neurosurgery devices are used for performing and treating pathologies in the central and peripheral nervous systems. They are mainly utilized for diagnosing, preventing, and treating neurological disorders and conditions like epilepsy and traumatic brain, depression, and spinal cord injuries. They also aid in conducting discectomies, microsurgeries and adjusting the skull bone during surgeries.
Global Neurosurgery Devices Market Trends:
The increasing incidences of neurological disorders, especially among the geriatric population, represents one of the key factors augmenting the market growth. Besides this, the growing awareness among the masses about the available effective treatments are also contributing to the growth of the market. Moreover, the leading manufacturers are introducing technological advancements, including the development of innovative minimally invasive (MI) equipment like liquid embolic and clot retrieval devices, flow diversion, balloon catheters and neuroendovascular stents. This, in confluence with improvements in the healthcare infrastructure and extensive research and development (R&D) activities, is positively influencing the market. On account of these factors, IMARC Group expects the global neurosurgery devices market to grow at a CAGR of 10.9% during 2024-2032.
Market Summary:
- Based on the product type, the market has been divided into neurointerventional devices, neurostimulation devices, neurosurgical navigation systems, cerebral spinal fluid (CSF) management devices and others.
- On the basis of the application, the market has been segmented into spinal cord stimulation (chronic pain, failed back surgery syndrome and ischemia), deep brain stimulation (Parkinson’s disease, tremor, depression and others) and neuroendoscopy (transnasal, intraventricular and transcranial).
- Based on the end-user, the market has been classified into hospitals, ambulatory surgical centers, and others.
- Region-wise, the market has been segregated into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa.
- The competitive landscape of the market has been examined, with some of the key players being Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, DePuy Synthes Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Nevro Corp, Nihon Kohden Corporation, Penumbra Inc., and Stryker Corporation.
Report Scope:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Product Type, Application, End-User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, DePuy Synthes Inc., Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Medtronic Plc, Nevro Corporation, Nihon Kohden Corporation, Penumbra Inc. and Stryker Corporation |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800